General description
LiChrosorb® RP-18 is a reliable irregular shaped silica gel carriers with reversed phase properties. It is well suited for the separation of neutral, acidic and weak basic compounds.
Application
Determination of berberine in human serum by reversed-phase high performance liquid chromatography.: This study outlines a method for detecting berberine in human serum using reversed-phase HPLC, utilizing the LiChrosorb RP-18 column for its reliability in separating chemical compounds in biological samples (Sun Y et al., 1997).
Kinetics of hydrolysis of 4-methoxy-2-[2-hydroxy-3(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine in aqueous solutions.: This research employs RP-18 to study the stability and hydrolysis kinetics of a complex organic compound, highlighting its application in pharmaceutical analysis (Muszalska I et al., 2004).
A validated spectrophotometric and liquid chromatography method for determination and purity evaluation of 4-methoxy-2-[2-hydroxy-3(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine.: This paper details the use of RP-18 in validating a method for assessing the purity of pharmaceutical compounds, demonstrating its essential role in quality control (Muszalska I et al., 2003).
High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients.: This study utilizes RP-18 to monitor fluconazole in clinical samples, providing insights into the pharmacokinetics and therapeutic monitoring of antifungal treatment in HIV patients (Beijnen JH et al., 1995).
Ion-pair solid-phase extraction of cimetidine from plasma and subsequent analysis by high-performance liquid chromatography.: Describes a method using RP-18 for the extraction and analysis of cimetidine, a drug used to treat heartburn and peptic ulcers, from plasma samples, illustrating its versatility in drug analysis (Russel FG et al., 1994).
Analysis Note
Theoretical Plates (N/m) (Toluene): ≥ 60000
stability testing (performance): passes test
separation factor (Acetophenone/Phenol, selectivity test): 1.8 – 2.2
separation factor (Acetophenone/Cinnamic acid, selectivity test): 1.1 – 1.4
separation factor (1-Naphtol/Phenol, selectivity test): 3.9 – 4.7
capacity factor (Toluene): 16.0 – 21.0
Particle Size (d10): 3.8 – 4.3 µm
Particle Size (d50): 6.7 – 7.7 µm
Particle Size (d90): 12.0 – 14.0 µm
Legal Information
LiChrosorb is a registered trademark of Merck KGaA, Darmstadt, Germany

Tiếng Việt